Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.5025
-0.0306 (-5.74%)
At close: Dec 2, 2025
Biotricity Market Cap
Biotricity has a market cap or net worth of $14.9 million as of December 2, 2025. Its market cap has increased by 115.78% in one year.
Market Cap
14.90M
Enterprise Value
43.21M
Revenue
15.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.50
Market Cap Chart
Since February 18, 2016, Biotricity's market cap has decreased from 187.13M to 14.90M, a decrease of -92.04%. That is a compound annual growth rate of -22.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 14.90M | 109.41% |
| Dec 31, 2024 | 7.12M | -31.33% |
| Dec 29, 2023 | 10.37M | -61.10% |
| Dec 30, 2022 | 26.65M | -88.14% |
| Dec 31, 2021 | 224.72M | 464.80% |
| Dec 31, 2020 | 39.79M | 13.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 486.41M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 318.36M |
| Nika Pharmaceuticals | 259.91M |